Skip to main content
Bodal Chemicals Ltd logo

Bodal Chemicals Ltd — Investor Relations & Filings

Ticker · BODALCHEM ISIN · INE338D01028 LEI · 33580055P81L7PGHUJ40 BSE.NS Manufacturing
Open in API
Filings indexed 1,550 across all filing types
Latest filing 2023-06-14 Regulatory Filings
Country IN India
Listing BSE.NS BODALCHEM

About Bodal Chemicals Ltd

https://www.bodal.com/

Bodal Chemicals Ltd is a vertically integrated manufacturer specializing in dyestuffs, dye intermediates, and basic chemicals. The product portfolio includes a wide range of reactive, acid, and direct dyes, alongside key intermediates such as H-Acid and Vinyl Sulphone. The chemical division produces sulfuric acid, chloro sulfonic acid, and liquid sulfur trioxide. By maintaining a high degree of backward integration, the company ensures cost-efficiency and consistent quality across its manufacturing chain. It serves diverse global markets, primarily catering to the textile, leather, paper, and plastic sectors. The organization focuses on large-scale production capabilities and technical expertise to provide chemical solutions for industrial applications worldwide.

Recent filings

Filing Released Lang Actions
Spurt in Volume
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the National Stock Exchange of India regarding a clarification on unusual price and volume movements of the company's stock. It explicitly states that there is no undisclosed information affecting the stock price and that the company complies with SEBI listing obligations. The document is a regulatory communication clarifying market behavior and compliance, not a financial report, earnings release, or any other specific filing type. It is short (1503 characters) and serves as a regulatory disclosure or clarification. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other categories.
2023-06-14 English
Bodal Chemicals Limited has informed the Exchange about Transcript
Regulatory Filings
2023-06-02 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 95% confidence The document is a detailed transcript of the Q4 and full fiscal year 2023 earnings conference call of Bodal Chemicals Limited. It includes management commentary on operational and financial performance, segment-wise revenue and volume data, and a Q&A session with analysts. The text explicitly mentions it is a transcript of the earnings call held on May 30, 2023, and contains detailed financial figures and business outlook discussion. This matches the definition of a Call Transcript (CT), which is a full text transcript of company conference calls such as earnings calls with Q&A. The document is not a brief earnings release (ER), nor is it an annual or interim report. It is not an announcement or a certification but the full transcript of the call. Therefore, the correct classification is CT with high confidence.
2023-06-02 English
Copy of Newspaper Publication
Annual Report Classification · 95% confidence The document contains a statement of audited standalone and consolidated financial results for the quarter and year ended March 31, 2023. It mentions approval by the Board of Directors and audit by statutory auditors with an unmodified opinion. The document includes detailed financial figures, notes on accounting standards, and references to SEBI regulations for financial disclosures. The length is over 7,000 characters and contains substantive financial data and analysis, not just an announcement or certification. Therefore, this is a comprehensive financial report for a full fiscal year, fitting the definition of an Annual Report (10-K equivalent). FY 2023
2023-05-31 English
Bodal Chemicals Limited has informed the Exchange about Copy of Newspaper Publication
Regulatory Filings
2023-05-31 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 90% confidence The document is a submission under SEBI regulations providing a link to the audio recording of the company's earnings call held on May 30, 2023, discussing the audited financial results for the year ended March 31, 2023. It does not contain the transcript or detailed financial data itself, only a reference and link to the recording. The document is short (1497 characters) and serves as an announcement of the availability of the earnings call recording. According to the classification rules, such a document is best classified as a Call Transcript (CT) because it relates to the earnings call, but since it only provides a link to the audio recording and not the transcript, it is more appropriate to classify it as a Regulatory Filing (RNS) as a general regulatory announcement and disclosure under SEBI regulations. However, given the specific nature of the content (earnings call audio recording announcement), the closest specific category is Call Transcript (CT) with moderate confidence, but the document does not contain the transcript itself. Therefore, the best fit is Regulatory Filings (RNS) with high confidence as it is a regulatory disclosure without substantive financial data or transcript text.
2023-05-30 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.